「news2022年12月」の検索結果
74件：66～70件目を表示
-
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
https://www.senju.co.jp/english/rd/trial.html -
NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines New Mytear® A Supplies moisture. CHARACTERISTICS This is an artificial tear-type eye drop with mild sensation. It supplies the moisture of tears that is important to the eyes
https://www.senju.co.jp/english/products/myteara.html -
Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject
https://www.senju.co.jp/english/about/production.html -
お知らせ | 千寿製薬株式会社
https://www.senju.co.jp/english/news/javascipt: void(0); -
お知らせ | 千寿製薬株式会社
April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approv
https://www.senju.co.jp/english/news/